Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favourable Risk Pediatric Hodgkin Lymphoma
This phase II trial is studying how well combination chemotherapy with or without radiation
therapy works in treating young patients with favourable-risk Hodgkin lymphoma. Drugs used in
chemotherapy, such as doxorubicin hydrochloride, vinblastine, mechlorethamine hydrochloride,
vincristine sulfate, bleomycin, etoposide, and prednisone, work in different ways to stop
the growth of cancer cells, either by killing the cells or by stopping them from dividing.
Giving more than one drug (combination chemotherapy) may kill more cancer cells. Radiation
therapy uses high-energy x-rays to kill cancer cells for those patients that still had
residual cancer at the end of chemotherapy. Giving combination chemotherapy with radiation
therapy may kill more cancer cells and allow doctors to save the part of the body where the
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society